Oramed Pharmaceuticals wins Japanese patent for oral delivery technology
The patent, titled "Methods and Compositions for Oral Administrations of Proteins," covers a core concept of the company’s technology. Oramed CEO Nadav Kidron said, "The Japanese patent approval
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.